Skip to main content
[Translate to English:]

Novo Nordisk Pharma GmbH

Dr. Robert Haustein, Senior Manager Govermental Affairs, Head of Capital Office, Novo Nordisk Pharma GmbH

 

1. Describe your company in a Tweet! 

Novo Nordisk is a global leader in healthcare, founded in 1923 and headquartered in Denmark. We drive change with the goal of defeating diabetes and other serious chronic diseases such as obesity and rare blood and metabolic disorders. To do this, we are working on breakthrough scientific innovations to the point of curing diseases. We promote access to our products for patients worldwide and are actively engaged in prevention. Novo Nordisk employs around 45,000 people in 80 countries and markets its products in around 170 countries. Around 480 employees work at the German headquarters in Mainz.

 

2. Why do you get involved as a Berlin Partner? 

As an internationally active company with Danish roots, we are convinced of Berlin and its importance for the healthcare industry in Germany and Europe.

 

Exclusive information for Berlin-Partners

Photocredit: © Novo Nordisk

TeilenShare

Weitere
Informationen
Further
Information

A small talk with Stefan Hoppe

14.07.2022
Interview with Stefan Hoppe, Managing Director ENERGY in Berlin & Commercial Director ENERGY MEDIA GmbH

Read more

Bonjour Paris

12.07.2022
Business delegation comprising representatives from politics, economy and culture visits Paris

Read more

BERLIN IS THE MOST POPULAR START-UP HUB IN EUROPE

08.07.2022
These are the key findings from the 2022 Startup Heat Map Report.

Read more

Premiere at the Berlin "Hoffest" courtyard festival 2022

06.07.2022

Read more

Tailwind for capital city electromobility conference

30.06.2022
The number of electric cars is increasing in the capital

Read more

Discover and test green mobility from Berlin

22.06.2022
The city of Berlin will appear at the Greentech Festival under the motto ‘green, sustainable mobility’

Read more